Breaking News
Get 55% Off 0
🏃 Grab this Black Friday offer early. Get up to 55% off InvestingPro now!
CLAIM SALE
Close

Fidelity Select Biotechnology Portfolio (FBIOX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
21.31 -0.73    -3.31%
12/11 - Delayed Data. Currency in USD
Type:  Fund
Market:  United States
Issuer:  Fidelity Investments
Underlying:  S&P 500 TR
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 4.89B
Fidelity Select Biotechnology 21.31 -0.73 -3.31%

FBIOX Overview

 
On this page you'll find an in-depth profile of Fidelity Select Biotechnology Portfolio. Learn about the key management, total assets, investment strategy and contact information of FBIOX among other information.
Category

Health

Total Assets

4.89B

Expenses

0.64%

Inception Date

Dec 16, 1985

Contact Information

Address 483 Bay Street
Toronto,ON M5G 2N7
Canada
Phone 416-307-5200
Fax 1-800-387-8092

Top Executives

Name Title Since Until
Rajiv Kaul Portfolio Manager 2005 Now
Biography Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.
Harlan P. Carere Portfolio Manager 2004 2005
Biography Carere is a portfolio manager of Fidelity Investments. He joined Fidelity International Limited in London in 2000 as an equity research analyst following the technology sector. He subsequently served as technology sector leader in the London office. Prior to joining the firm, he was an equity analyst for Berman Capital.
Andraz Razen Vice President 2002 2004
Biography Andraz Razen is an equity portfolio manager at Capital Group. As an equity investment analyst at Capital, Andraz is a generalist covering small-cap companies. He has 25 years of investment experience and has been with Capital Group for 18 years. Earlier in his career, as an equity investment analyst at Capital, he also covered U.S. health care and supplies companies. Prior to joining Capital, he was an analyst and portfolio manager at Fidelity Investments in Boston. He holds a bachelor's degree in quantitative economics from Tufts University graduating summa cum laude. Andraz is based in London.
Brian Younger Research Analyst, Portfolio Manager 2000 2002
Biography Younger is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in June 1998, he has worked as a research analyst and portfolio manager.
Yolanda S. Strock equity analyst/portfolio Manager 2000 2000
Biography Yolanda Strock joined Fidelity in 1997 where she is the sector leader of the Health Care Equity Resesarch group. She began managing Fidelity Select Biotechnology Portfolio in February 2000, and assumed her other fund management responsibilities and role of sector leader in June 2000. Yolanda has an MBA in Finance from the Fuqua School of Business at Duke University, a BSc in Marketing from the Wharton School of Business and a BA in economics from the University of Pennsylvania.
Rajiv Kaul Portfolio Manager 1998 2000
Biography Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.
James M. Harmon Portfolio Manager 1997 1998
Biography Mr. Harmon is a portfolio manager with Fidelity Investments, his employer since 1995. He joined the firm as an equity analyst covering biotechnology and smaller health-care services companies. Previously, Mr. Harmon has worked as a research analyst, portfolio assistant in Fidelity Investments. Before that he was a junior analyst with Essex Investment Management Co., Inc.
Karen Firestone - 1992 1997
Michael S. Gordon Portfolio Manager 1990 1992
Biography Gordon has been a portfolio manager with Fidelity Investments since 1990. He joined Fidelity Investments in June 1987 as a research analyst covering initial public offerings.
Steven Kaye Co-Manager 1985 1989
Biography Kaye is a vice president and portfolio manager with Fidelity Management & Research. Previously, he was head of Fidelity Select Portfolios and assistant director of research. Since joining Fidelity Investments in 1985, Mr. Kaye has worked as a research analyst, assistant director of equity research, and portfolio manager. Before joining the firm, he spent two years as a research analyst with Strategic Planning Associates.
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FBIOX Comments

Write your thoughts about Fidelity Select Biotechnology Portfolio
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email